Close

Regulus Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Recent Updates Mar 21, 2024 04:05PM
Regulus Therapeutics (RGLS) Enters $100M Oversubscribed Private Placement Mar 12, 2024 06:33AM
Regulus Therapeutics Announces Oversubscribed $100 Million Private Placement of Equity Mar 12, 2024 06:32AM
Regulus Therapeutics Reports First Quarter 2023 Financial Results and Recent Updates May 11, 2023 04:05PM
Regulus Therapeutics (RGLS) Announces $15M Private Placement Apr 13, 2023 08:01AM


Apr 13, 2023 08:00AM Regulus Therapeutics Announces $15 Million Private Placement of Equity
Mar 10, 2022 04:05PM Regulus Therapeutics Reports Fourth Quarter and Year-End 2021 Financial Results and Recent Updates
Nov 24, 2021 04:06PM Regulus Therapeutics (RGLS) Announces 58.9M Share Private Placement at $0.36/sh
Nov 24, 2021 04:05PM Regulus Therapeutics Announces Private Placement of Equity
Mar 9, 2021 04:07PM Regulus Therapeutics Reports Fourth Quarter and Year-End 2020 Financial Results and Recent Updates
Dec 7, 2020 05:06PM Form 4 Regulus Therapeutics For: Dec 04 Filed by: New Enterprise Associates 16, L.P.
Jun 11, 2019 06:12AM Regulus Therapeutics (RGLS) Appoints Jake Nunn and Simos Simeonidis, Ph.D. to Board
Jun 11, 2019 05:00AM Regulus Announces New Additions to Board of Directors
May 6, 2019 09:00AM Regulus Therapeutics Announces Private Placement of Equity